Tweet
Highlights and conclusions from the technical consultative meeting on novel coronavirus infection, Cairo, Egypt, 14?16 January 2013 (WHO/EMRO, abstract)
[Source: Eastern Mediterranean Health Journal, full PDF document: http://applications.emro.who.int/emhj/v19/Supp1/EMHJ_2013_19_Supp1_S68_S74.pdf. Abstract, edited.]
Meeting report
Highlights and conclusions from the technical consultative meeting on novel coronavirus infection, Cairo, Egypt, 14?16 January 2013
C. Joseph,1 M.R. Malik,2 A.W. Mounts,1 A. R. Mafi,2 S. Briand,1 Z.A. Memish 3,4 and the technical working group for the meeting on novel coronavirus
(1)Global Influenza Programme, Department of Pandemic and Epidemic Disease. World Health Organization, Geneva, Switzerland. (2)Pandemic and Epidemic Disease, Department of Communicable Disease Prevention and Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt (Correspondence to M.R. Malik: malikm@who.int). (3)Ministry of Health, Riyadh, Saudi Arabia. (4)College of Medicine, Al Faisal University, Riyadh, Saudi Arabia.
ABSTRACT
The emergence of a novel strain of coronavirus in the Arabian Peninsula raised a global health concern in 2012, partly because the majority of human infections were fatal and partly due to its presumed animal origin. An urgent meeting of scientific and public health experts was convened by WHO in January 2013 in view of the limited knowledge available on the epidemiological and natural history of infection with this novel virus. The meeting reviewed current evidence and identified critical knowledge gaps to improve better understanding of the public health risk associated with the virus so as to improve preparedness and to safeguard and protect global health.
-
------
Meeting report
Highlights and conclusions from the technical consultative meeting on novel coronavirus infection, Cairo, Egypt, 14?16 January 2013
C. Joseph,1 M.R. Malik,2 A.W. Mounts,1 A. R. Mafi,2 S. Briand,1 Z.A. Memish 3,4 and the technical working group for the meeting on novel coronavirus
(1)Global Influenza Programme, Department of Pandemic and Epidemic Disease. World Health Organization, Geneva, Switzerland. (2)Pandemic and Epidemic Disease, Department of Communicable Disease Prevention and Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt (Correspondence to M.R. Malik: malikm@who.int). (3)Ministry of Health, Riyadh, Saudi Arabia. (4)College of Medicine, Al Faisal University, Riyadh, Saudi Arabia.
ABSTRACT
The emergence of a novel strain of coronavirus in the Arabian Peninsula raised a global health concern in 2012, partly because the majority of human infections were fatal and partly due to its presumed animal origin. An urgent meeting of scientific and public health experts was convened by WHO in January 2013 in view of the limited knowledge available on the epidemiological and natural history of infection with this novel virus. The meeting reviewed current evidence and identified critical knowledge gaps to improve better understanding of the public health risk associated with the virus so as to improve preparedness and to safeguard and protect global health.
-
------